S100A8 and lung cancer: Control mice had extensive lung cancers (HBSS: 49.9 ± 10.5 mm2), whereas only small cancer nodules were present in S100A8-treated mice (8.4 ± 4.6 mm2) (p < 0.01) (Figures 1A-C).